CRISIL Limited (IN:CRISIL)
:CRISIL
Want to see IN:CRISIL full AI Analyst Report?
Top Page
CRISIL Limited
(CRISIL)
Select Model
Select Model
Rating:68Neutral
Price Target:
₹4,422.00
▼(-6.19% Downside)
Action:ReiteratedDate:02/18/26
The score is primarily supported by strong financial performance (durable margins, solid ROE, and generally healthy cash generation). It is tempered by weaker technical positioning (trading below major moving averages with subdued momentum) and a demanding valuation (high P/E with only a modest dividend yield).
Positive Factors
Profitability / Margins
Consistently high net and EBITDA margins reflect durable pricing power and a scalable analytics business. These margins support reinvestment into products, sustain earnings through cycles, and underpin long-term return on equity and free cash flow generation.
Negative Factors
Rising Debt Levels
A recent rise in total debt diminishes CRISIL's prior ultra-low leverage buffer, increasing interest and refinancing risk. Higher leverage can constrain strategic optionality, reduce flexibility for M&A or payouts, and raises vulnerability to macro shocks over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability / Margins
Consistently high net and EBITDA margins reflect durable pricing power and a scalable analytics business. These margins support reinvestment into products, sustain earnings through cycles, and underpin long-term return on equity and free cash flow generation.
Read all positive factors
CRISIL Limited (CRISIL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹318.07B
Dividend Yield1.38%
Average Volume (3M)4.38K
Price to Earnings (P/E)29.5
Beta (1Y)0.86
Revenue Growth6.61%
EPS Growth11.88%
CountryIN
Employees4,666
SectorServices
Sector StrengthN/A
IndustryFinancial - Data & Stock Exchanges
Share Statistics
EPS (TTM)31.90
Shares Outstanding73,130,020
10 Day Avg. Volume6,165
30 Day Avg. Volume4,375
Financial Highlights & Ratios
PEG Ratio3.45
Price to Book (P/B)10.42
Price to Sales (P/S)8.66
P/FCF Ratio45.21
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)127.17
Revenue Forecast (FY)₹42.87B
CRISIL Limited Business Overview & Revenue Model
Company Description
CRISIL Limited, an analytical company, together with its subsidiaries, provides ratings, data, research, and analytics and solutions in India, Europe, North America, and internationally. It operates through three segments: Ratings, Research, and A...
How the Company Makes Money
CRISIL primarily makes money by charging fees for analytical and advisory services delivered across its major business lines. (1) Credit ratings: CRISIL earns rating fees from issuers (such as corporates, banks/NBFCs, and public-sector entities) w...
CRISIL Limited Financial Statement Overview
Summary
Income Statement
86
Very Positive
Balance Sheet
82
Very Positive
Cash Flow
78
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 36.49B | 32.60B | 31.40B | 27.69B | 23.01B |
| Gross Profit | 12.77B | 16.81B | 13.92B | 13.78B | 11.39B |
| EBITDA | 10.85B | 10.00B | 9.75B | 8.52B | 7.33B |
| Net Income | 7.66B | 6.84B | 6.58B | 5.64B | 4.66B |
Balance Sheet | |||||
| Total Assets | 46.32B | 39.42B | 32.97B | 28.31B | 25.04B |
| Cash, Cash Equivalents and Short-Term Investments | 10.10B | 13.74B | 11.52B | 8.43B | 7.42B |
| Total Debt | 5.44B | 2.50B | 473.20M | 834.60M | 1.32B |
| Total Liabilities | 15.98B | 13.77B | 11.08B | 10.39B | 9.25B |
| Stockholders Equity | 30.33B | 25.65B | 21.89B | 17.92B | 15.78B |
Cash Flow | |||||
| Free Cash Flow | 6.99B | 5.92B | 7.17B | 4.15B | 3.80B |
| Operating Cash Flow | 7.72B | 7.65B | 7.80B | 4.56B | 4.03B |
| Investing Cash Flow | -2.85B | -3.86B | -3.27B | -616.40M | -882.50M |
| Financing Cash Flow | -4.70B | -4.42B | -4.08B | -3.68B | -2.91B |
CRISIL Limited Technical Analysis
Neutral
4713.95
Price Trends
4275.94
Positive
4386.74
Negative
4769.50
Negative
Market Momentum
-27.14
Negative
62.85
Neutral
89.88
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CRISIL, the sentiment is Neutral. The current price of 4713.95 is above the 20-day moving average (MA) of 3958.55, above the 50-day MA of 4275.94, and below the 200-day MA of 4769.50, indicating a neutral trend. The MACD of -27.14 indicates Negative momentum. The RSI at 62.85 is Neutral, neither overbought nor oversold. The STOCH value of 89.88 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:CRISIL.
CRISIL Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹47.94B | 33.44 | ― | 1.23% | 19.50% | 33.27% | |
72 Outperform | ₹51.86B | 37.64 | ― | 0.97% | 8.06% | 24.52% | |
68 Neutral | ₹318.07B | 29.48 | ― | 1.38% | 6.61% | 11.88% | |
55 Neutral | $13.29B | 17.42 | 10.03% | 0.93% | 7.13% | -12.93% |
* Services Sector Average
IN:CRISIL
CRISIL Limited
4,349.40
-360.00
-7.64%
IN:CARERATING
CARE Ratings Ltd
1,595.30
387.52
32.09%
IN:ICRA
ICRA Limited
5,373.50
-433.40
-7.46%
CRISIL Limited Corporate Events
CRISIL Sets Record Date for First Interim Dividend for FY 2026
Apr 8, 2026
CRISIL Limited has announced that it has set April 23, 2026 as the record date for determining shareholders eligible to receive the first interim dividend for the financial year ending December 31, 2026. The dividend remains subject to approval by...
Crisil Disputes Tax Re-assessment Order Raising INR 121.20 Crore Demand
Mar 24, 2026
Crisil Limited has disclosed that it received a re-assessment order under Section 147 for financial year 2016-17 related to its merged subsidiaries, even though their income had already been consolidated and offered to tax. While the Assessing Off...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.